Saturday, December 29, 2012 12:51:25 PM
+CSO is a world reknown Scientist and former head of Neurotrophic Factors at NIH and professor at world reknown McGill University): https://www.michaeljfox.org/foundation/researchers.php?id=1015 (notice where this link goes to?)
+Money poured into GDNF at same stage of testing (which has had worse results than MANF) ~ $250 Million
+GDNF had issues with poor diffusion rates and had issues with binding heparin with high affinity both of which aren't characteristics of MANF
+Money poured into Neurturin, another protein in the class of neurotrophic factors, which is in stage I ~ $150 Million
+Patent protection - upheld in court vs Hermo Pharma, a VC backed and MJFF funded biotech firm
+A partner at Hermo Pharma even admitted that the company's MANF patents cause "an undue burden on anyone trying to test MANF because it covers anything with a 90% homology (ie similarity) to MANF: http://m.seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s
+Founder of Amgen believes it could be the biggest success he has ever seen. He is also presenting alongside the CSO on 1/8/13 in front of a crowd of Pharma companies and VC investors about the commercial opportunities that exist for MANF.
AMBS is an EPIC Stock. EPIC Stocks can be found once every 5 years or so. They go up several hundred fold over the span of 6 to 12 months because their potential is so much greater than the market realized and it collectively comes to an aha moment. For people like us who got in and hold from the .02 to .03 level or below we will net a 20 to 100 bagger. 99.99% of investors lack patience to hold throughout.. The patient ones will make out like bandits. Bashers/impatient investors will continue to watch it go higher in disbelief that they sold or never got in when it was staring them right in their eyes.
Stars are aligned for a move to $0.40+ shortly. The market cap at $23 million is way too small for this company given the above facts. We will continue to go higher much to the chagrin of every naysayer / disbeliever.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM